Fig. 6.

Survival analysis of UACC903(+6) and UACC903 cell lines. (a) Survival curves of UACC903(+6) and UACC903 cells in response to FAS ligand (FASLG) at the doses of 50, 100, 200, and 400 ng/ml. (b) time–response curves of the cells to the treatment with 100 ng/ml of FASLG. (c) Effects of the siRNA knockdown of BAK1 protein on survival of UACC903(+6) cells following BAK1 siRNA transfection. (d) Western blot analysis of BAK1 protein levels in UACC903(+6) cells following BAK1 siRNA transfection. Mock-T (M-T): mock transfection with no-specific siRNA; siR:siRNA; B-F: BAK1-siR—FASLG